Title : Dual targeting of Bcl-2 and VEGF: a potential strategy to improve therapy for prostate cancer.

Pub. Date : 2011 Jul-Aug

PMID : 19576799






1 Functional Relationships(s)
Download
Sentence
Compound Name
Protein Name
Organism
1 Interestingly, targeting Bcl-2 with ASO resulted in the inhibition of in vitro tube formation and inhibition of angiogenesis in Matrigel plugs similar to treatment with bevacizumab. 1,5-anhydroglucitol BCL2 apoptosis regulator Homo sapiens